DK0472706T3 - Induktion af beskyttelse mod viral infektion - Google Patents
Induktion af beskyttelse mod viral infektionInfo
- Publication number
- DK0472706T3 DK0472706T3 DK91906386.7T DK91906386T DK0472706T3 DK 0472706 T3 DK0472706 T3 DK 0472706T3 DK 91906386 T DK91906386 T DK 91906386T DK 0472706 T3 DK0472706 T3 DK 0472706T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- induction
- antibodies
- protection against
- viral infection
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000006698 induction Effects 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 230000003472 neutralizing effect Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 230000010530 Virus Neutralization Effects 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49474990A | 1990-03-19 | 1990-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0472706T3 true DK0472706T3 (da) | 1997-12-29 |
Family
ID=23965805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91906386.7T DK0472706T3 (da) | 1990-03-19 | 1991-03-16 | Induktion af beskyttelse mod viral infektion |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP0742229A3 (da) |
| JP (2) | JPH03271233A (da) |
| AT (1) | ATE154244T1 (da) |
| AU (3) | AU651816B2 (da) |
| CA (1) | CA2057040A1 (da) |
| DE (1) | DE69126486T2 (da) |
| DK (1) | DK0472706T3 (da) |
| ES (1) | ES2104695T3 (da) |
| GR (1) | GR3024670T3 (da) |
| WO (1) | WO1991014449A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
| US5876724A (en) * | 1990-03-19 | 1999-03-02 | Institut Pasteur | Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| US6139843A (en) * | 1991-04-02 | 2000-10-31 | Albert Einstein College Of Medicine Of Yeshiva University | Peptide compositions for the treatment of HIV |
| EP0536352B1 (en) * | 1991-04-02 | 2003-12-17 | Albert Einstein College Of Medicine Of Yeshiva University | Therapeutic and preventive vaccines for hiv |
| JPH07501052A (ja) * | 1991-10-28 | 1995-02-02 | インスティチュート・パスツール | ウイルスエンベロープタンパク質と糖タンパク質の中和エピトープに相当するペプチドとの間の相乗作用によるウイルス感染に対する防御の誘発 |
| FR2692898B1 (fr) * | 1992-06-30 | 1995-06-02 | Centre Nat Rech Scient | Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination. |
| UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3688051T2 (de) * | 1985-12-17 | 1993-06-24 | Akzo Nv | Immunochemisches reagenz. |
| NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
| ATE128716T1 (de) * | 1987-11-24 | 1995-10-15 | Abbott Lab | Hiv-peptide und methoden für den nachweis von hiv. |
| US5039522A (en) * | 1988-01-29 | 1991-08-13 | New York Blood Center, Inc. | Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen |
| CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| FR2650954B1 (fr) * | 1989-08-18 | 1992-02-28 | Pasteur Institut | Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida |
-
1990
- 1990-11-30 JP JP2341189A patent/JPH03271233A/ja active Pending
-
1991
- 1991-03-16 EP EP96106172A patent/EP0742229A3/en not_active Withdrawn
- 1991-03-16 DE DE69126486T patent/DE69126486T2/de not_active Expired - Fee Related
- 1991-03-16 CA CA002057040A patent/CA2057040A1/en not_active Abandoned
- 1991-03-16 WO PCT/EP1991/000509 patent/WO1991014449A1/en active IP Right Grant
- 1991-03-16 DK DK91906386.7T patent/DK0472706T3/da active
- 1991-03-16 JP JP3506292A patent/JPH04506220A/ja active Pending
- 1991-03-16 AT AT91906386T patent/ATE154244T1/de not_active IP Right Cessation
- 1991-03-16 ES ES91906386T patent/ES2104695T3/es not_active Expired - Lifetime
- 1991-03-16 EP EP91906386A patent/EP0472706B1/en not_active Expired - Lifetime
- 1991-03-16 AU AU74989/91A patent/AU651816B2/en not_active Ceased
-
1994
- 1994-06-09 AU AU64615/94A patent/AU6461594A/en not_active Abandoned
-
1997
- 1997-09-10 GR GR970402313T patent/GR3024670T3/el unknown
-
1998
- 1998-06-16 AU AU71960/98A patent/AU7196098A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2057040A1 (en) | 1991-09-20 |
| GR3024670T3 (en) | 1997-12-31 |
| JPH04506220A (ja) | 1992-10-29 |
| AU7196098A (en) | 1998-08-13 |
| EP0742229A2 (en) | 1996-11-13 |
| ES2104695T3 (es) | 1997-10-16 |
| EP0742229A3 (en) | 1998-06-03 |
| DE69126486T2 (de) | 1998-01-15 |
| EP0472706B1 (en) | 1997-06-11 |
| DE69126486D1 (de) | 1997-07-17 |
| AU7498991A (en) | 1991-10-21 |
| AU651816B2 (en) | 1994-08-04 |
| AU6461594A (en) | 1994-09-08 |
| EP0472706A1 (en) | 1992-03-04 |
| JPH03271233A (ja) | 1991-12-03 |
| ATE154244T1 (de) | 1997-06-15 |
| WO1991014449A1 (en) | 1991-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
| EA200100619A1 (ru) | Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов | |
| FI941199A0 (fi) | Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset | |
| DE69526339T2 (de) | Monoklonale antikörper, die an den vorläufer des tumorabstossantigen mage-1 anbinden, rekombinantes mage-1, und von mage-1 abgebieteteimmunogene peptide | |
| DE69126301T2 (de) | Hiv-induzierte synzytien blockierender anti-cd-4-antikörper | |
| DK1278534T3 (da) | Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1 | |
| CA2091263A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| GR3029264T3 (en) | Anti-feline immunodeficiency virus (fiv) vaccines. | |
| DK0472706T3 (da) | Induktion af beskyttelse mod viral infektion | |
| DK0714307T3 (da) | Vaccinesammensætninger | |
| DK0439601T3 (da) | Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| SE9600436D0 (sv) | Vaccine against hantavirus | |
| DE69112392D1 (de) | Bcrf1-antagonisten zur behandlung von epstein-barr-virus-infektionen. | |
| DK0470989T3 (da) | Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer | |
| RU93004854A (ru) | Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека |